UTR-26247-06616
3 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 981 / WA
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- SDL-95537-29575
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-04-09
Dose 1 — Pfizer-BioNTech
-
2022-04-30
Dose 2 — Pfizer-BioNTech
-
2022-06-20
Registered in v-safe
- 2022-07-30
-
2022-10-19
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-29
- 2022-10-29
- 2022-11-02
- 2022-11-09
- 2022-11-16
-
2022-11-25
Survey response — day 35, dose 3, dependentMedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Sniffles/coldMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Survey response — day 42, dose 3, dependentMedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Coughing and congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-18
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-04-09 | Pfizer-BioNTech | No |
| 2 | 2022-04-30 | Pfizer-BioNTech | No |
| 3 | 2022-10-19 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 35, dose 3, dependent
Symptoms: Sniffles/cold
Release 12 — day 42, dose 3, dependent
Symptoms: Coughing and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release